Choose a country to view content specific to your location
Choose a country to view content specific to your location
Small Cell Lung Cancer (SCLC) is an aggressive form of lung cancer characterized by rapid growth and early metastasis. To support research and diagnostic assay development related to SCLC, Meridian Bioscience offers a monoclonal antibody specifically targeting small cell lung carcinoma. This antibody aids in the detection and study of SCLC, providing a valuable tool for understanding this malignancy.
Contact us to learn more about Meridian’s molecular or immunoassay reagent portfolio. We want to hear from you!
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.
| Type |
|---|
| Format |
| Host/Source |
| Isotype |
| Tested Apps |
| Unit |
| Catalog |
| Buffer |
| Immunogen |
| COFA Description |
| COFA Notes |
| Recombination |
| SDS |
| COA |
| Product Information Sheet |
| Request Sample |
